KLRC1 and neoplasm: NKG2A is, contrary to primary NK cells, one of the few inhibitory receptors expressed by CD276-CAR NK-92 cells and their respective tumor cell ligands, HLA-E and HLA-G, are commonly overexpressed in cutaneous melanoma [22,56,71].